NOVELLUS

novellus-logo

Novellus is a biotechnology company working to develop engineered cellular medicines. The company uses its non-immunogenic mRNA molecules to reprogram and gene-edit cells safely, and with high efficiency. They engineer precision medicines for patient segments and select from its technology toolbox for in vivo, ex vivo, allogeneic and autologous delivery. Novellus platform enables the high-level expression of gene-editing and cell-reprogramming proteins for high-specificity gene repair and both autologous and allogeneic cell therapies. The company is advancing its lead program, a breakthrough therapy for a rare dermatologic disease, through pre-clinical studies. Novellus was founded in 2015 and is headquartered in Cambridge, Massachusetts, United States.

#SimilarOrganizations #People #Financial #Website #More

NOVELLUS

Social Links:

Industry:
Biotechnology Health Care Life Science Medical

Founded:
2014-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.novellustx.com

Total Employee:
11+

Status:
Active

Contact:
617-285-2632

Email Addresses:
[email protected]

Total Funding:
58 M USD

Technology used in webpage:
SPF Unified Layer Hostgator Mail BlueHost BlueHost DNS


Similar Organizations

acthera-therapeutics-logo

Acthera Therapeutics

Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery

adicet-bio-logo

Adicet Bio

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

arima-genomics-logo

Arima Genomics

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

arna-genomics-logo

ARNA Genomics

ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.

aro-biotherapeutics-logo

Aro Biotherapeutics

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

black-diamond-therapeutics-logo

Black Diamond Therapeutics

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.

chroma-medicine-logo

Chroma Medicine

Chroma Medicine is a new genomic medicine company working on epigenetic editing.

fauna-bio-logo

Fauna Bio

Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.

generate-biomedicines-logo

Generate Biomedicines

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

genova-logo

Genova

Genova is a biotechnology company focusing on the development and production of insulin.

instil-bio-logo

Instil Bio

Instil Bio is a biotechnology company that develops cell therapies for solid tumor cures.

invenra-logo

Invenra

Invenra operates as a biotechnology company focused on early stage drug discovery.

inventprise-logo

Inventprise

Inventprise is a biotechnology company specializing in GMP vaccine product development.

lytica-therapeutics-logo

Lytica Therapeutics

Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.

naveris-logo

Naveris

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

neutrolis-logo

Neutrolis

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).

aobiome-logo

AOBiome

AOBiome is a life sciences company that focuses on transforming human health.

fore-biotherapeutics-logo

Fore Biotherapeutics

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

q32-bio-logo

Q32 Bio

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

rootpath-genomics-logo

RootPath Genomics

RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.

seer-logo

Seer

Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

sojournix-logo

Sojournix

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

synthorx-logo

Synthorx

Synthorx is a biotechnology company using synthetic biology to synthesize solutions.

tempus-logo

Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

trestle-biotherapeutics-logo

Trestle Biotherapeutics

Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease.

tulavi-therapeutics-logo

Tulavi Therapeutics

Tulavi Therapeutics is a medical device company that develops products to improve surgical care of peripheral nerve injury.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Founder


matt-angel_image

Matt Angel

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Novellus

pontifax_image

Pontifax

Pontifax investment in Series C - Novellus

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Novellus

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Novellus

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Novellus

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Novellus

Official Site Inspections

http://www.novellustx.com

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Novellus"

Novellus - Crunchbase Company Profile & Funding

Novellus is a biotechnology company working to develop engineered cellular medicines. The company uses its non-immunogenic mRNA molecules to reprogram and gene-edit cells safely, and with high efficiency. They engineer …See details»

Novellus - Overview, News & Similar companies | ZoomInfo.com

View Novellus (www.novellustx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»

Novellus Therapeutics - PitchBook

Information on acquisition, funding, cap tables, investors, and executives for Novellus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Novellus Therapeutics - Drug pipelines, Patents, Clinical trials

Novellustx.com. 2014 | United States | < 10 | novellustx.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ...See details»

Novellus Therapeutics - VentureRadar

Website: https://novellustx.com/ Develops advanced cellular therapies utilizing patented non-immunogenic mRNA, precise gene editing, mutation-free cell reprogramming, and serum …See details»

Novellus, Inc. Financial Overview, Employee Count, and Competitors

View Novellus, Inc. (http://www.novellustx.com) location in Massachusetts, United States, revenue, competitors and contact information. Find and reach Novellus, Inc.'s employees by …See details»

Brooklyn ImmunoTherapeutics Executes Letter of Intent to

Jun 14, 2021 · Novellus is a pre-clinical stage biotechnology company developing engineered cellular medicines using its licensed patented non-immunogenic mRNA, high-specificity gene …See details»

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire ...

Jun 14, 2021 · Novellus is a pre-clinical stage biotechnology company developing engineered cellular medicines using its licensed patented non-immunogenic mRNA, high-specificity gene …See details»

Novellus Therapeutics - Products, Competitors, Financials, …

Novellus Therapeutics strives to develop treatments for pernicious diseases using the cell engineering technologies. It is based in Massachusetts, U.S. On July 16th, 2021, Novellus …See details»

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal …

Oct 13, 2020 · NoveCite will develop and commercialize Novellus's iMSCs to treat acute respiratory conditions with a near term focus on Acute Respiratory Distress Syndrome …See details»

Novellus Therapeutics Exclusively Licenses Induced ... - BioSpace

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ -- Novellus Therapeutics ("Novellus"), an engineered cellular medicines company, announced today that it has licensed its induced …See details»

Brooklyn ImmunoTherapeutics Executes Letter of Intent to Acquire ...

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ('Brooklyn'), a biopharmaceutical company focus...See details»

Industry Updates from the Field of Stem Cell Research and …

Oct 27, 2021 · Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions …See details»

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal …

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ -- Novellus Therapeutics ("Novellus"), an engineered cellular medicines company, announced today that it has licensed its induced …See details»

Novellus Therapeutics Exclusively Licenses Induced Mesenchymal …

Oct 13, 2020 · NoveCite will develop and commercialize Novellus's iMSCs to treat acute respiratory conditions with a near term focus on Acute Respiratory Distress Syndrome …See details»

Novellus-动脉网 - vbdata.cn

Jan 1, 2014 · Novellus是一家生物技术公司,致力于开发工程细胞药物。 该公司使用其非免疫原性的mRNA分子安全高效地对细胞进行重新编程和基因编辑。 他们为患者细分市场设计精密药 …See details»

Meta Developers - Oculus VR

Manage your organization. Create your organization. Add financial settings. Get financial reports. Verify your org. Manage multiple orgs. Manage test users. Business models and strategy. …See details»

Log in to your Okta org

If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more. Learn …See details»

Novellus Therapeutics | VentureRadar

Website: https://novellustx.com/ Develops advanced cellular therapies utilizing patented non-immunogenic mRNA, precise gene editing, mutation-free cell reprogramming, and serum …See details»

Organisation vs. Organization: What’s the Difference?

In this article, I’ll compare organisation vs. organization. I’ll use each one in a sentence. Then, I’ll give you a helpful trick to remember whether to use organisation or organization in your …See details»

linkstock.net © 2022. All rights reserved